The tweet was deleted by the author.
But we saved everything 🙂.
ACADIA Pharmaceuticals is participating in the 47th National Conference on Pediatric Health Care this week, inviting attendees to visit Booth 408 and connect with its team.
The company is sharing its latest data on Rett syndrome and offering information about ongoing research and resources. This presence underscores ACADIA Pharmaceuticals' commitment to supporting pediatric health care professionals and advancing awareness around Rett syndrome at a key industry gathering.
ACADIA Pharmaceuticals’ active engagement at major industry events continues to reflect its focus on advancing research in central nervous system disorders. Recent participation in the Stifel 2026 Virtual CNS Forum highlighted the company’s broader strategies in CNS therapies, while its unveiling of new Rett syndrome research at the Baltimore genetics meeting underscored ongoing efforts to deepen clinical understanding of rare pediatric diseases.